At UCB we are committed to improving patients’ lives and advancing scientific research and medical knowledge. We support a variety of initiatives through our external funding programs, including Investigator-Initiated Studies (IIS), Grants, Donations and Sponsorships.

All completed requests that meet our review criteria and are submitted with sufficient notice will be reviewed and considered for support. However, UCB receives numerous proposals and is unable to support every request.

Requests for funding from UCB may be submitted through eRequest, UCB’s online submission portal.

Donations

UCB provides Donations to organizations / institutions that raise awareness of the needs of those with severe diseases, further medical and scientific knowledge, and build strong communities in areas where UCB operates.

Grants

UCB provides Grants for programs that foster increased understanding of scientific, clinical, and healthcare issues and that contribute to the enhancement of patient care.

Sponsorships

UCB accepts requests for Sponsorships to support activities which further medical and scientific knowledge. In return, UCB receives benefits such as opportunities to promote our products, our company, and/or specific disease awareness activities.

Investigator-Initiated Studies

The purpose of the UCB Investigator-Initiated Studies (IIS) program is to support unsolicited, and independently initiated and conducted studies that have the potential to enhance medical and scientific knowledge. UCB support may be requested in the form of funding and/or investigational drug supply.

Requests for funding, for Grants, Donations and Sponsorships, from UCB Canada Inc. may be submitted through a detailed letter of request via email to UCBCanada. GrantsandSponsorships

@ucb.com. Information on what must be included in the letter of request is provided in the UCB Canada Funding Request document below.

All requests for funding for Investigator-initiated Studies (IIS) must be submitted through eRequest, UCB's online submission portal.